Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMO: Decolonization for Recurrent MRSA
NCT00560599Phase 3Completed
- Start
- Apr 2007
- Primary completion
- Feb 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mupirocin, chlorhexidine + cymenol gel in Staphylococcus aureus infection. Started Apr 2007; status: completed.
02
Drugs
mupirocinchlorhexidine + cymenol gel
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT00560599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560599.